| Date Filed | Type | Description |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2023 |
4
| Studer Jacqueline (Chief Legal Officer) has filed a Form 4 on Akili, Inc.|
Txns:
| Granted 29,000 shares
@ $0
Granted 117,000 options to buy
@ $1.56, valued at
$182.5k
|
|
| 12/13/2022 |
3/A
| Studer Jacqueline (Chief Legal Officer) has filed a Form 3/A on Akili, Inc. |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2018 |
4
| Studer Jacqueline (CVP, Gen. Counsel & Secretary) has filed a Form 4 on IDEXX LABORATORIES INC /DE|
Txns:
| Sold 3,313 shares
@ $201.2746, valued at
$666.8k
|
|
| 09/04/2018 |
4
| Studer Jacqueline (CVP, Gen. Counsel & Secretary) has filed a Form 4 on IDEXX LABORATORIES INC /DE|
Txns:
| Paid exercise price by delivering 524 shares
@ $254.04, valued at
$133.1k
Exercised 1,129 restricted stock units
@ $0 |
|
| 08/23/2018 |
4
| Studer Jacqueline (CVP, Gen. Counsel & Secretary) has filed a Form 4 on IDEXX LABORATORIES INC /DE|
Txns:
| Exercised 2,219 shares
@ $141.6, valued at
$314.2k
Sold 5,549 shares
@ $243.359, valued at
$1.4M
Sold 2,806 shares
@ $244.1514, valued at
$685.1k
Sold 3,264 shares
@ $245.0634, valued at
$799.9k
Exercised 9,400 options to buy
@ $67.85, valued at
$637.8k
Sold 2,219 options to buy
@ $141.6, valued at
$314.2k
|
|
| 08/10/2018 |
4
| Studer Jacqueline (CVP, Gen. Counsel & Secretary) has filed a Form 4 on IDEXX LABORATORIES INC /DE|
Txns:
| Exercised 1,783 options to buy
@ $79.54, valued at
$141.8k
Exercised 2 options to buy
@ $67.85, valued at
$135.7 |
|
| 08/07/2018 |
4
| Studer Jacqueline (CVP, Gen. Counsel & Secretary) has filed a Form 4 on IDEXX LABORATORIES INC /DE|
Txns:
| Sold 5,588 shares
@ $242.0963, valued at
$1.4M
Sold 3,010 shares
@ $242.8694, valued at
$731k
Exercised 8,598 options to buy
@ $79.54, valued at
$683.9k
|
|
| 05/31/2018 |
4
| Studer Jacqueline (CVP, Gen. Counsel & Secretary) has filed a Form 4 on IDEXX LABORATORIES INC /DE|
Txns:
| Sold 475 shares
@ $209.9804, valued at
$99.7k
Exercised 1,185 options to buy
@ $79.54, valued at
$94.3k
|
|
| 02/16/2018 |
4
| Studer Jacqueline (CVP, Gen. Counsel & Secretary) has filed a Form 4 on IDEXX LABORATORIES INC /DE|
Txns:
| Paid exercise price by delivering 298 shares
@ $178.26, valued at
$53.1k
Granted 8,007 options to buy
@ $178.26, valued at
$1.4M
Granted 560 options to buy
@ $178.26, valued at
$99.8k
Granted 841 restricted stock units
@ $0
Exercised 346 restricted stock units
@ $0
Exercised 406 restricted stock units
@ $0
Exercised 212 restricted stock units
@ $0 |
|
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/02/2016 |
4
| Studer Jacqueline (CVP, Gen. Counsel & Secretary) has filed a Form 4 on IDEXX LABORATORIES INC /DE|
Txns:
| Paid exercise price by delivering 365 shares
@ $113.16, valued at
$41.3k
Exercised 1,129 restricted stock units
@ $0 |
|
| 02/17/2016 |
4
| Studer Jacqueline (See Remarks) has filed a Form 4 on IDEXX LABORATORIES INC /DE|
Txns:
| Paid exercise price by delivering 130 shares
@ $67.85, valued at
$8.8k
Paid exercise price by delivering 130 shares
@ $67.85, valued at
$8.8k
Granted 22,027 options to buy
@ $67.85, valued at
$1.5M
Granted 22,027 options to buy
@ $67.85, valued at
$1.5M
Granted 1,477 options to buy
@ $67.85, valued at
$100.2k
Granted 1,477 options to buy
@ $67.85, valued at
$100.2k
Granted 2,027 restricted stock units
@ $0
Exercised 346 restricted stock units
@ $0 |
|
| 09/03/2015 |
4
| Studer Jacqueline (CVP, Gen. Counsel & Secretary) has filed a Form 4 on IDEXX LABORATORIES INC /DE|
Txns:
| Paid exercise price by delivering 365 shares
@ $70.54, valued at
$25.7k
Exercised 1,130 restricted stock units
@ $0 |
|
| 02/18/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/03/2014 |
4
| Studer Jacqueline (CVP, Gen. Counsel & Secretary) has filed a Form 4 on IDEXX LABORATORIES INC /DE|
Txns:
| Granted 2,823 restricted stock units
@ $0 |
|
| 09/05/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2012 |
4
| Studer Jacqueline (Sr. VP and General Counsel) has filed a Form 4 on ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.|
Txns:
| Granted 22,790 shares
@ $0 |
|
| 05/03/2012 |
4
| Studer Jacqueline (Sr. VP and General Counsel) has filed a Form 4 on ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.|
Txns:
| Granted 25,047 shares
@ $0 |
|
| 09/02/2011 |
4
| Studer Jacqueline (EVP and General Counsel) has filed a Form 4 on ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.|
Txns:
| Granted 27,840 shares
@ $0
Granted 2,784 shares
@ $0 |
|
| 07/22/2011 |
3
| Studer Jacqueline (Sr. VP and General Counsel) has filed a Form 3 on ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. |